Avac (SRP299): Phase I trial update

Genesis Research and Development Corp. (NZSE/ASX:GEN), Auckland, New

Read the full 82 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE